Conquering hepatitis C, step by step

被引:18
作者
Schafer, DF [1 ]
Sorrell, MF [1 ]
机构
[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA
关键词
D O I
10.1056/NEJM200012073432309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1723 / 1724
页数:2
相关论文
共 11 条
[1]   Hepatitis C virus and eliminating post-transfusion hepatitis [J].
Alter, HJ ;
Houghton, M .
NATURE MEDICINE, 2000, 6 (10) :1082-1086
[2]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]   RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
MARTIN, P ;
KASSIANIDES, C ;
LISKERMELMAN, M ;
MURRAY, L ;
WAGGONER, J ;
GOODMAN, Z ;
BANKS, SM ;
HOOFNAGLE, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1506-1510
[4]   A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C [J].
Glue, P ;
Rouzier-Panis, R ;
Raffanel, C ;
Sabo, R ;
Gupta, SK ;
Salfi, M ;
Jacobs, S ;
Clement, RP .
HEPATOLOGY, 2000, 32 (03) :647-653
[5]   Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis [J].
Heathcote, EJ ;
Shiffman, ML ;
Cooksley, WGE ;
Dusheiko, GM ;
Lee, SS ;
Balart, L ;
Reindollar, R ;
Reddy, RK ;
Wright, TL ;
Lin, A ;
Hoffman, J ;
De Pamphilis, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) :1673-1680
[6]   Hepatitis c in African Americans: Summary of a workshop [J].
Howell, C ;
Jeffers, L ;
Hoofnagle, JH .
GASTROENTEROLOGY, 2000, 119 (05) :1385-+
[7]   Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C [J].
Imai, Y ;
Kawata, S ;
Tamura, S ;
Yabuuchi, I ;
Noda, S ;
Inada, M ;
Maeda, Y ;
Shirai, Y ;
Fukuzaki, T ;
Kaji, I ;
Ishikawa, H ;
Matsuda, Y ;
Nishikawa, M ;
Seki, K ;
Matsuzawa, Y .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) :94-99
[8]   The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C [J].
McHutchison, JG ;
Poynard, T ;
Pianko, S ;
Gordon, SC ;
Reid, AE ;
Dienstag, J ;
Morgan, T ;
Yao, RJ ;
Albrecht, J .
GASTROENTEROLOGY, 2000, 119 (05) :1317-1323
[9]   Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].
McHutchison, JG ;
Gordon, SC ;
Schiff, ER ;
Shiffman, ML ;
Lee, WM ;
Rustgi, VK ;
Goodman, ZD ;
Ling, MH ;
Cort, S ;
Albrecht, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492
[10]   Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy [J].
Neumann, AU ;
Lam, NP ;
Dahari, H ;
Gretch, DR ;
Wiley, TE ;
Layden, TJ ;
Perelson, AS .
SCIENCE, 1998, 282 (5386) :103-107